Vestische Children´s Hospital
Datteln, 45711, Germany
NCT Number: NCT00435734
The intervention program "Obeldicks" was developed for obese children aged 6 to 16 years. This intervention is gender- and age specific. The 12-months intervention is based on nutrition course, behaviour therapy and exercise therapy. The evaluation compromised quality of structure, process and results of the intervention. Primary outcome measure is change of weight status as standard deviation score of BMI. Furthermore, cardiovascular risk factor profile, hormones (e.g. iGF-I, thyroid hormones, vitamin D status)adipocytokines, GI- hormones, intima media thickness are measured prior to and after the one-year intervention. The changes of these hormones and adipocytokines will allow to answer the questions whether the alterations of these hormones are a cause or consequence of overweight. Additionally, a genetic screening is performed to characterize the participants to probably predict response to intervention.
This study is active but is not currently recruiting participants.
Notify Me6 year–18 year
All sexes
Observational
Datteln, 45711, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 20 years
Time frame: 10 years
Time frame: 10 years
Time frame: 10 years
Time frame: 10 years
Time frame: 10 years
University of Witten/Herdecke
Other
Evaluation of the Intervention Program "Obeldicks" for Obese Children and Adolescents
Acronym: Obeldicks
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04335799
Body Weight, Nutrition Disorders
Tampa, Florida, United States
View Trial DetailsNCT05198765
Body Weight, Diabetes Mellitus
Minneapolis, Minnesota, United States
View Trial DetailsNCT00739362
Body Weight, Body Weight Changes
Phoenix, Arizona, United States
View Trial DetailsNCT07400653
Body Weight, Diabetes Mellitus
Anaheim, California, United States
View Trial Details